Anti-CEACAM6 mAb 8F5 has a significant synergistic effect when used in combination with the chemotherapy drug paclitaxel, showing 80% tumor growth inhibition in vitro xenograft models [48]. This evidence concerns the gene CEACAM6 and neoplasm.